Effects of TRPC6 on invasibility of low-differentiated prostate cancer cells

Asian Pacific Journal of Tropical Medicine

Volumn 7, Issue 1, 2014, Pages 44-47

  Wang, Dong ^a   Li, Xiang ^b   Liu, Jing ^a   Li, Jun ^a   Li, Li Jun ^a   Qiu, Ming Xing ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Invasion; Prostate cancer; Retroviruses; Stable cell line; TRPC6

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ARTICLE; CANCER CELL; CELL INVASION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING;

INVASION; PROSTATE CANCER; RETROVIRUSES; STABLE CELL LINE; TRPC6;

CELL LINE, TUMOR; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RETROVIRIDAE; RNA, MESSENGER; TRPC CATION CHANNELS;

EID: 84892175494     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(13)60190-X     Document Type: Article

References (28)

1. Hanahan D, Weinberg RA The hallmarks of cancer. Cell 2000, 100(1):57-70.
2. Dal Pra A, Cury FL, Souhami L Radiation therapy and androgen deprivation in the management of high risk prostate cancer. Int Braz J Urol 2011, 37(2):161-175.
3. Pezaro C, Attard G Redefining the therapeutic landscape for CRPC. Nat Rev Urol 2012, 9(2):63-64.
4. Saad F, Hotte SJ Guidelines for the management of castrate-resistant prostate cancer. Can Urol Assoc J 2010, 4(6):380-384.
5. Fizazi K, Carducci M, Smith M, Damião R, Brown J, Karsh L, et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer:a randomised, double-blind study. Lancet 2011, 377(9768):813-822.
6. Björkman M, Östling P, Härmä V, Virtanen J, Mpindi JP, Rantala J, et al. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene 2012, 31(29):3444-3456.
7. van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RCM, et al. Targeting of α v-Integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia 2011, 13(6):516-525.
8. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA Molecular biology of bone metastasis. Mol Cancer Ther 2007, 6(10):2609-2617.
9. Fabian A, Fortmann T, Dieterich P TRPC1 channels regulate directionality of migrating cells. Signaling Cell Physiol 2008, 457:475-484.
10. Meyer T, Hart IR Mechanism of tumour metastasis. Eur J Cancer 1998, 34(2):214-221.
11. Wcsxthouse EC, Chuaqui RF, Liotta LA General mechanis'ms of metastasis. Cx3P Cer 1997, 80(8 Suppl):1529-1537.
12. Autio-Harmainen H, Karttunen T, Hurskainen T, Höyhtyä M, Kauppila A, Tryggvason K Expression of72Kda type IV collagenase in benign and malignant ovarian tumors. Lab Invest 1993, 69:312-321.
13. Stearns MA, Wang M Type IV collagenase expression in humane prostate:benign and malignant tissue. Cancer Res 1993, 53:878-883.
14. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, et al. Activity of type IV colla-genases in benign and malignant breast disease. Br J Cancer 1993, 67:1126-1131.
15. Derrico A, Garbisa S Augmentation of collagenase IV, laminin receptor and Ki62proliferation antigen associated with human colon. Mod Pathol 1991, 4:239-246.
16. Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, et al. Expreasion od membrane-type matrix metalloproteinase1in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Res 1996, 56:5678-5683.
17. Kleiner DE, Stetler-Stevenson WG Matrix metallopro-teinases and metastasis. Cancer Chemother Pharmcol 1999, 43(Suppl):42-51.
18. Prevarskaya N, Zhang L, Barritt G TRP channels in cancer. Biochimica et Biophysica Acta 2007, 1772:937-946.
19. 2+/NFAT-dependent pathways. Oncogene 2007, 26:7380-7385.
20. Bomben VC, Sontheimer H Disruption of transient receptor potential canonicalchannel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas. GLIA 2010, 58:1145-1156.
21. El Hiani Y, Lehen'kyi V, Ouadid-Ahidouch H, Ahidouch A Activation of the calcium-sensing receptor by high calcium induced breast cancer cell proliferation and TRPC1 cation channel over-expression potentially through EGFR pathways. Arch Biochem Biophysics 2009, 486(1):58-63.
22. Fabian A, Fortmann T, Dieterich P, Riethmüller C, Schön P, Mally S, et al. TRPC1 channels regulate directionality of migrating cells. Pflugers Arch Eur J Physiol 2008, 457:475-484.
23. Spinsanti G, Zannolli R, Panti C, Ceccarelli I, Marsili L, Bachiocco V, et al. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J Cancer Res Clin Oncol 2009, 135:507-514.
24. Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, et al. Enhanced expression of t ransient receptor potential channels in idiopat hic pulmonary arterial hypertension. Proc Nat l Acad Sci USA 2004, 101(38):13861-13866.
25. 2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line. Cell Physiol 2005, 201(1):320-328.
26. Yue D, Wang Y, Xiao JY, Wang P, Ren CS Expression of TRPC6 in benign and malignant human prostate tissues. Asian J Androl 2009, 11:541-547. 10.1038/aja.2009.53.
27. Wang Y, Yue D, Li K, Liu YL, Ren CS, Wang P The role of TRPC6 in HGF-induced cell proliferation of human prostate cancer DU145 and PC3 cells. Asian J Androl 2010, 12:841-852. 10.1038/aja.2010.85.
28. 2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 2006, 66:2038-2047.